Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Assets Average (2021 - 2023)

Cullinan Therapeutics has reported Assets Average over the past 3 years, most recently at $508.3 million for Q3 2023.

  • Quarterly results put Assets Average at $508.3 million for Q3 2023, down 20.85% from a year ago — trailing twelve months through Sep 2023 was $508.3 million (down 20.85% YoY), and the annual figure for FY2022 was $499.2 million, up 53.14%.
  • Assets Average for Q3 2023 was $508.3 million at Cullinan Therapeutics, down from $518.5 million in the prior quarter.
  • Over the last five years, Assets Average for CGEM hit a ceiling of $642.2 million in Q3 2022 and a floor of $347.2 million in Q1 2021.
  • Median Assets Average over the past 3 years was $508.3 million (2023), compared with a mean of $500.9 million.
  • Biggest five-year swings in Assets Average: skyrocketed 39.96% in 2022 and later dropped 20.85% in 2023.
  • Cullinan Therapeutics' Assets Average stood at $445.3 million in 2021, then skyrocketed by 32.31% to $589.2 million in 2022, then decreased by 13.72% to $508.3 million in 2023.
  • The last three reported values for Assets Average were $508.3 million (Q3 2023), $518.5 million (Q2 2023), and $538.1 million (Q1 2023) per Business Quant data.